← Back to headlines
Amicus Therapeutics Reports Non-GAAP EPS of $0.31 and Revenue of $634M
Amicus Therapeutics announced its non-GAAP earnings per share of $0.31 and reported revenues of $634 million.
20 Feb, 21:10 — 20 Feb, 21:10
Amicus Therapeutics announced its non-GAAP earnings per share of $0.31 and reported revenues of $634 million.
20 Feb, 21:10 — 20 Feb, 21:10